Canada - Re-Export of Insulin in Dosage Forms
Since 2014, Canada Re-Export of Insulin in Dosage Forms fell by 13.3% year on year. With $1,644,202.25 in 2019, the country was ranked number 6 comparing other countries in Re-Export of Insulin in Dosage Forms. Canada is overtaken by Barbados, which was ranked number 5 at $2,381,725.2 and is followed by New Zealand at $285,616.07. United Arab Emirates ranked the highest with $37,345,759.11 in 2019, a fall of 4.3% compared to 2018. United States, Jordan and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. United Arab Emirates recorded the best 5 years average growth at +119.7% per year, while Canada was the worst growing country at -13.3% per year.
Loading...
Date | US Dollars |
---|---|
2019 | 1,644,202.25 |
2018 | 3,044,109.50 |
2017 | 639,452.13 |
2016 | 43,251,344.00 |
2015 | 3,004,687.00 |
Download all data from 2005 to 2019
How does Canada rank in Re-Export of Insulin in Dosage Forms?
# | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United Arab Emirates
|
37,345,759.11 | 2019 | -4.3 % | +119.7 % | View data | |
2 |
#2
United States
|
6,604,316.00 | 2019 | -8.0 % | +47.1 % | View data | |
5 |
#5
Barbados
|
2,381,725.20 | 2019 | +2.5 % | -1.6 % | View data | |
6 |
#6
Canada
|
1,644,202.25 | 2019 | -46.0 % | -13.3 % | View data | |
7 |
#7
New Zealand
|
285,616.07 | 2019 | +18.1 % | +1.7 % | View data |